GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

tositumomab   Click here for help

GtoPdb Ligand ID: 6781

Synonyms: Bexxar® | V10XA53
Approved drug Immunopharmacology Ligand
tositumomab is an approved drug (FDA (2003))
Compound class: Antibody
Comment: Tositumomab was used as a radioimmunotherapy drug, targeting CD20 on B-lymphocytes prior to cessation of its manufacture.
Immunopharmacology Disease
Disease X-Refs Comment References
non-Hodgkin lymphoma Disease Ontology: DOID:0060060
OMIM: 605027
 Approved for CD20 positive follicular non-Hodgkin's lymphoma but production/sales were ceased by the manufacturer in 2014.